NCT05487404View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

May 29, 2022

Study Completion Date

May 29, 2022

Conditions
Ethanol Intoxication
Interventions
DRUG

ADX-629

3 oral doses of ADX-629 600 milligrams

DRUG

Placebo

3 oral doses of placebo

Trial Locations (1)

45230

Medpace Clinical Pharmacology, Cincinnati

Sponsors
All Listed Sponsors
lead

Aldeyra Therapeutics, Inc.

INDUSTRY